Oncotarget
Representative images of immunohistochemical staining for Extracellular Sulfatase Sulf-2 (SULF2) in pediatric Glioblastoma (GBM). See Phillips et al.
Targeting Protein-Tyrosine Phosphatases in Breast Cancer |
https://doi.org/10.18632/oncotarget.496 Nicola Aceto, and Mohamed Bentires-Alj |
514-515 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Voltage-dependent K+ channels as oncotargets in malignant gliomas |
https://doi.org/10.18632/oncotarget.514 Florence Lefranc, Henri-Benjamin Pouleau, Michal Rynkowski, and Olivier De Witte |
516-517 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A novel co-operative mechanism linking TGFβ and Lyn kinase activation to imatinib resistance in chronic myeloid leukaemia cells |
https://doi.org/10.18632/oncotarget.500 Andrew Chantry, Paul G Smith, and Hideo Tanaka |
518-524 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells |
https://doi.org/10.18632/oncotarget.491 Elisabeth J. Walsby, Laurence Pearce, Alan K. Burnett, Chris Fegan, and Chris Pepper |
525-534 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma. |
https://doi.org/10.18632/oncotarget.498 Francesco Sottile, Ilaria Gnemmi, Sandra Cantilena, Walter C. D'Acunto, and Arturo Sala |
535-545 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase. |
https://doi.org/10.18632/oncotarget.503 Hongdo Do, and Alexander Dobrovic |
546-558 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Solid Tumor Differentiation Therapy – Is It Possible? |
https://doi.org/10.18632/oncotarget.512 Filemon Dela cruz, and Igor Matushansky |
559-567 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Novel Therapeutic Targets in the Brain Tumor Microenvironment |
https://doi.org/10.18632/oncotarget.526 Joanna J. Phillips |
568-575 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
FLT3 in lineage specification and plasticity |
https://doi.org/10.18632/oncotarget.499 Sarah Greenblatt, and Donald Small |
576-580 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Cell-based high-throughput screens for the discovery of chemotherapeutic agents |
https://doi.org/10.18632/oncotarget.513 Jennifer T Fox, and Kyungiae Myung |
581-585 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Mantle cell lymphoma-like lymphomas in c-myc-3’RR/p53+/- mice and c-myc-3’RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin |
https://doi.org/10.18632/oncotarget.474 Pauline Rouaud, Rémi Fiancette, Christelle Vincent-Fabert, Virginie Magnone, Michel Cogné, Pierre Dubus, and Yves Denizot |
586-593 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC